Principal Securities, Inc. Axonics, Inc. Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 230 shares of AXNX stock, worth $16,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
230
Previous 218
5.5%
Holding current value
$16,196
Previous $14.7 Million
9.22%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AXNX
# of Institutions
230Shares Held
42.9MCall Options Held
50.2KPut Options Held
165K-
Vanguard Group Inc Valley Forge, PA5.04MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$306 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.18MShares$153 Million6.99% of portfolio
-
Fil LTD Hamilton, D02.04MShares$144 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$125 Million2.93% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.46B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...